Patents by Inventor Glen Weiss

Glen Weiss has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8911940
    Abstract: Methods and kits that use miRNA expression to predict the development of brain metastases in non-small cell lung cancer patients are disclosed.
    Type: Grant
    Filed: July 29, 2010
    Date of Patent: December 16, 2014
    Assignees: The Translational Genomics Research Institute, Scottsdale Healthcare Corporation
    Inventors: Glen Weiss, Seungchan Kim, Sara Nasser
  • Publication number: 20120178093
    Abstract: Methods and kits that use miRNA expression to predict the development of brain metastases in non-small cell lung cancer patients are disclosed.
    Type: Application
    Filed: July 29, 2010
    Publication date: July 12, 2012
    Applicants: SCOTTSDALE HEALTHCARE, THE TRANSLATIONAL GENOMICS RESEARCH INSTITUTE
    Inventors: Glen Weiss, Seungchan Kim, Sara Nasser
  • Publication number: 20120149586
    Abstract: Disclosed herein are methods of predicting the risk of recurrence of cancer on the basis of the expression of microRNA of the miR-520 family.
    Type: Application
    Filed: August 14, 2009
    Publication date: June 14, 2012
    Applicants: SCOTTSDALE HEALTHCARE, THE TRANSLATIONAL GENOMICS RESEARCH INSTITUTE
    Inventor: Glen Weiss
  • Publication number: 20120095030
    Abstract: Methods of using specific microRNA to identify subjects with non-small cell lung cancer likely or unlikely to respond to treatment with tyrosine kinase inhibitors such as erlotinib, sunitinib, or vandetanib; methods of treating subjects based on identification of said subjects as likely to respond to treatment with tyrosine kinase inhibitors; and kits that facilitate the performance of the methods are disclosed.
    Type: Application
    Filed: April 19, 2010
    Publication date: April 19, 2012
    Applicant: THE TRANSLATIONAL GENOMICS RESEARCH INSTITUTE
    Inventor: Glen Weiss
  • Publication number: 20110124700
    Abstract: Methods of assessing the sensitivity of a cancer cell to a tyrosine kinase inhibitor are disclosed. Such methods include assessing the expression of miR-497 and correlating reduced expression with sensitivity to the tyrosine kinase inhibitor. Also disclosed are methods of assessing the sensitivity of a cell to a tyrosine kinase inhibitor that includes assessing the expression of FGF1, HOXC10, and/or LHFP. Additionally disclosed are methods of treating patients with tyrosine kinase inhibitors such as sunitinib based on results obtained from the disclosed methods and kits that facilitate the methods.
    Type: Application
    Filed: February 19, 2009
    Publication date: May 26, 2011
    Inventor: Glen Weiss